Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.19.3.a.u2
Condensed Consolidated Balance Sheets - USD ($)
Dec. 31, 2019
Jun. 30, 2019
Current assets:    
Cash $ 147,246 $ 30,142
Accounts receivable - net 54,135 45,086
Inventories 374,523 406,439
Other current assets 2,040 1,000
Total current assets 577,944 482,667
Intangible asset placement fee -net 972,354
Total assets 1,550,298 482,667
Current liabilities:    
Accounts payable 1,114,344 496,809
Accrued expense-related party 9,974 33,974
Convertible notes payable - net of discount 1,624,400 1,117,741
Fair value of derivative liabilities 1,765,728 1,306,748
Total current liabilities 4,514,446 2,955,272
Commitments and contingencies
Stockholders' deficit:    
Preferred stock, ($0.001 par value, 100,000,000 shares authorized, and 1,000 issued and outstanding as of December 31, 2019 and 1,000 outstanding as of June 30, 2019, respectively) 1 1
Common stock, ($0.001 par value, 200,000,000 shares authorized, and 57,109,093 issued and outstanding as of December 31, 2019 and 53,773,856 outstanding as of June 30, 2019, respectively) 57,109 53,774
Additional paid in capital 11,701,922 10,692,679
Accumulated deficit (14,723,180) (13,219,059)
Total stockholders' deficit (2,964,148) (2,472,605)
Total Liabilities and Stockholders' Deficit $ 1,550,298 $ 482,667